LIDOCAINE

LIDOCAINE was reported 61323 times

LIDOCAINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 628 0.5913
1 INSPIRATORY CAPACITY DECREASED 88 0.3177
2 SLEEP DISORDER THERAPY 61 0.3081
3 APPENDICOLITH 89 0.2300
4 ANALGESIC THERAPY 61 0.1900
5 DRUG THERAPY 61 0.1799
6 INFUSION SITE DISCHARGE 303 0.1726
7 TOXIC ANTERIOR SEGMENT SYNDROME 177 0.1622
8 MATERNAL EXPOSURE DURING DELIVERY 158 0.1594
9 INFUSION SITE MASS 140 0.1288
10 INFUSION SITE BRUISING 263 0.1216
11 INFUSION SITE URTICARIA 79 0.1179
12 INFUSION SITE PRURITUS 356 0.1127
13 METHAEMOGLOBINAEMIA 251 0.1083
14 LAGOPHTHALMOS 43 0.1051
15 INFUSION SITE HAEMORRHAGE 341 0.1036
16 INFUSION SITE SCAR 43 0.0971
17 PRODUCT ADHESION ISSUE 3453 0.0965
18 INFUSION SITE RASH 118 0.0859
19 INFUSION SITE SWELLING 520 0.0826
20 INFUSION SITE NODULE 74 0.0770
21 INFUSION SITE DISCOMFORT 79 0.0762
22 CAUDA EQUINA SYNDROME 53 0.0690
23 INFUSION SITE IRRITATION 81 0.0630
24 PROCEDURAL HYPOTENSION 52 0.0611
25 INFUSION SITE ERYTHEMA 507 0.0601
26 INFUSION SITE WARMTH 73 0.0595
27 ANAESTHETIC COMPLICATION 159 0.0592
28 ANAESTHETIC COMPLICATION NEUROLOGICAL 53 0.0585
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62 0.0584
30 INFUSION SITE PAIN 751 0.0582
31 ALLERGIC SINUSITIS 48 0.0559
32 DEVICE INFUSION ISSUE 138 0.0556
33 INFUSION SITE EXTRAVASATION 329 0.0528
34 MULTIPLE ALLERGIES 410 0.0522
35 INCORRECT DRUG ADMINISTRATION RATE 220 0.0516
36 INFUSION SITE DISCOLOURATION 43 0.0489
37 KOUNIS SYNDROME 109 0.0480
38 ADMINISTRATION SITE PAIN 53 0.0460
39 INSURANCE ISSUE 699 0.0457
40 NEPHROGENIC ANAEMIA 211 0.0455
41 HYPERPARATHYROIDISM SECONDARY 111 0.0443
42 HYPERPHOSPHATAEMIA 95 0.0441
43 APPLICATION SITE DISCOMFORT 78 0.0434
44 INFUSION SITE REACTION 124 0.0415
45 SEASONAL ALLERGY 567 0.0400
46 HYPERTHERMIA MALIGNANT 58 0.0390
47 VASOPLEGIA SYNDROME 61 0.0372
48 RETINAL VASCULITIS 44 0.0369
49 INFUSION SITE INDURATION 54 0.0364
50 BLOOD PHOSPHORUS INCREASED 93 0.0340
51 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1772 0.0323
52 DERMATITIS CONTACT 365 0.0320
53 CORNEAL OEDEMA 68 0.0303
54 PULSELESS ELECTRICAL ACTIVITY 122 0.0292
55 OBSTRUCTION 114 0.0285
56 RESPIRATORY TRACT INFECTION VIRAL 64 0.0275
57 EAR INFECTION 689 0.0259
58 SINUSITIS 2575 0.0251
59 REBOUND ACID HYPERSECRETION 76 0.0251
60 VENTRICULAR FIBRILLATION 279 0.0251
61 CHRONIC SINUSITIS 94 0.0250
62 POOR VENOUS ACCESS 256 0.0247
63 RESPIRATORY TRACT INFECTION 644 0.0247
64 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 79 0.0238
65 PRODUCT DISTRIBUTION ISSUE 221 0.0238
66 PRODUCT QUALITY ISSUE 3211 0.0236
67 STRESS CARDIOMYOPATHY 131 0.0225
68 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 135 0.0218
69 VENTRICULAR TACHYCARDIA 358 0.0217
70 LUNG OPACITY 57 0.0216
71 UPPER RESPIRATORY TRACT INFECTION 992 0.0214
72 PARAPLEGIA 61 0.0211
73 IRON DEFICIENCY 95 0.0211
74 END STAGE RENAL DISEASE 378 0.0207
75 ANAPHYLACTIC SHOCK 522 0.0202
76 PULSE ABSENT 96 0.0202
77 STREPTOCOCCAL INFECTION 111 0.0199
78 VASCULAR DEVICE INFECTION 90 0.0198
79 INFUSION SITE INFECTION 46 0.0198
80 CATHETER SITE PAIN 51 0.0196
81 INGROWING NAIL 46 0.0195
82 ANIMAL BITE 51 0.0191
83 RHINOVIRUS INFECTION 73 0.0187
84 SKIN ABRASION 87 0.0184
85 TYPE I HYPERSENSITIVITY 64 0.0182
86 PHARYNGITIS STREPTOCOCCAL 196 0.0181
87 SKIN INFECTION 203 0.0181
88 OTITIS MEDIA 59 0.0178
89 AORTIC STENOSIS 62 0.0178
90 GENERALISED TONIC-CLONIC SEIZURE 294 0.0177
91 GASTROENTERITIS VIRAL 319 0.0177
92 STATUS EPILEPTICUS 197 0.0174
93 VENTRICULAR HYPOKINESIA 56 0.0174
94 CARDIOGENIC SHOCK 250 0.0174
95 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 46 0.0173
96 LUMBAR SPINAL STENOSIS 50 0.0171
97 MENINGITIS ASEPTIC 76 0.0169
98 HYPOPHOSPHATAEMIA 125 0.0169
99 MYASTHENIA GRAVIS 135 0.0167
100 APNOEA 129 0.0166
101 OXYGEN SATURATION ABNORMAL 47 0.0165
102 TOOTH INFECTION 217 0.0164
103 HAEMODYNAMIC INSTABILITY 124 0.0163
104 HYPERCAPNIA 48 0.0159
105 TENDERNESS 164 0.0157
106 GASTROINTESTINAL INFECTION 141 0.0157
107 LYME DISEASE 52 0.0156
108 BLOOD URIC ACID INCREASED 89 0.0154
109 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 79 0.0154
110 SKIN LACERATION 166 0.0153
111 HORDEOLUM 66 0.0152
112 DEAFNESS NEUROSENSORY 50 0.0152
113 BUNDLE BRANCH BLOCK LEFT 64 0.0151
114 SINUS TACHYCARDIA 214 0.0151
115 VENTRICULAR ARRHYTHMIA 55 0.0150
116 ANHEDONIA 393 0.0149
117 BRONCHITIS 1104 0.0149
118 ARTHRITIS BACTERIAL 61 0.0148
119 ANAPHYLACTIC REACTION 819 0.0148
120 BRONCHIECTASIS 99 0.0147
121 RENAL INJURY 430 0.0145
122 PROCTALGIA 93 0.0144
123 SINUS DISORDER 285 0.0144
124 APPENDICITIS 134 0.0143
125 KIDNEY INFECTION 279 0.0142
126 ATELECTASIS 137 0.0142
127 BACTERIAL INFECTION 260 0.0139
128 EYE INFECTION 156 0.0138
129 RESPIRATORY SYNCYTIAL VIRUS INFECTION 120 0.0138
130 VIRAL INFECTION 457 0.0137
131 MULTI-ORGAN FAILURE 237 0.0137
132 FEAR 360 0.0134
133 SPINAL CORD COMPRESSION 52 0.0133
134 SPINAL OSTEOARTHRITIS 117 0.0133
135 PARADOXICAL DRUG REACTION 49 0.0133
136 INTERVERTEBRAL DISC DEGENERATION 123 0.0133
137 WEIGHT FLUCTUATION 139 0.0133
138 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 67 0.0132
139 PARANASAL SINUS DISCOMFORT 50 0.0132
140 PSEUDOMONAS INFECTION 113 0.0132
141 FOOD POISONING 70 0.0131
142 VENTRICULAR EXTRASYSTOLES 135 0.0130
143 TOOTH ABSCESS 132 0.0130
144 ENDOPHTHALMITIS 77 0.0128
145 PRODUCT ADMINISTRATION INTERRUPTED 100 0.0127
146 RESPIRATORY ACIDOSIS 50 0.0127
147 RESPIRATORY DEPRESSION 155 0.0126
148 HYPOXIA 441 0.0125
149 DECUBITUS ULCER 102 0.0125
150 PNEUMONIA FUNGAL 49 0.0124
151 ARTHROPOD BITE 92 0.0124
152 UNRESPONSIVE TO STIMULI 319 0.0123
153 FOOD ALLERGY 95 0.0123
154 POST PROCEDURAL INFECTION 100 0.0123
155 ORAL INFECTION 48 0.0123
156 CARDIAC ARREST 1004 0.0121
157 INFUSION RELATED REACTION 806 0.0121
158 CANDIDA INFECTION 205 0.0121
159 PHARYNGITIS 150 0.0121
160 LOCALISED INFECTION 292 0.0121
161 ARTHRITIS INFECTIVE 56 0.0121
162 LIVE BIRTH 101 0.0121
163 NYSTAGMUS 64 0.0120
164 PARANASAL SINUS HYPERSECRETION 46 0.0120
165 NEURALGIA 291 0.0120
166 BREATH SOUNDS ABNORMAL 59 0.0120
167 HYPERVOLAEMIA 59 0.0119
168 SINUS BRADYCARDIA 114 0.0118
169 HYPERLIPIDAEMIA 140 0.0117
170 BRADYCARDIA 616 0.0116
171 STAPHYLOCOCCAL INFECTION 380 0.0115
172 GASTRIC INFECTION 44 0.0115
173 NEUROTOXICITY 199 0.0113
174 CYSTITIS 361 0.0113
175 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 194 0.0113
176 SENSORY LOSS 91 0.0113
177 TROPONIN INCREASED 86 0.0113
178 POST PROCEDURAL COMPLICATION 217 0.0113
179 BRAIN OEDEMA 142 0.0112
180 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 99 0.0112
181 CHRONIC KIDNEY DISEASE 842 0.0111
182 TORSADE DE POINTES 86 0.0110
183 MENINGITIS 73 0.0109
184 MENTAL STATUS CHANGES 303 0.0109
185 CONCUSSION 84 0.0108
186 MYDRIASIS 139 0.0108
187 GLUCOSE TOLERANCE IMPAIRED 64 0.0108
188 PERIPHERAL VASCULAR DISORDER 55 0.0107
189 URINARY TRACT INFECTION 1812 0.0106
190 RIB FRACTURE 217 0.0105
191 BRONCHOSPASM 150 0.0105
192 APPLICATION SITE RASH 143 0.0104
193 MYOCLONUS 124 0.0104
194 ESCHERICHIA INFECTION 85 0.0103
195 ABSCESS LIMB 44 0.0103
196 PROCEDURAL COMPLICATION 79 0.0103
197 NORMAL NEWBORN 56 0.0103
198 IMMUNE THROMBOCYTOPENIA 47 0.0103
199 VARICOSE VEIN 53 0.0103
200 COVID-19 1795 0.0102
201 RALES 59 0.0101
202 ILLNESS 1045 0.0101
203 RHINITIS ALLERGIC 45 0.0101
204 PRE-EXISTING CONDITION IMPROVED 63 0.0101
205 COVID-19 PNEUMONIA 119 0.0101
206 INTERVERTEBRAL DISC DISORDER 43 0.0101
207 CIRCULATORY COLLAPSE 171 0.0100
208 HYPOAESTHESIA ORAL 151 0.0100
209 BODY HEIGHT DECREASED 107 0.0100
210 HEPARIN-INDUCED THROMBOCYTOPENIA 49 0.0099
211 SCAR 169 0.0099
212 INABILITY TO AFFORD MEDICATION 98 0.0099
213 LEFT VENTRICULAR DYSFUNCTION 66 0.0098
214 CELLULITIS 496 0.0098
215 DIVERTICULUM INTESTINAL 43 0.0098
216 SKIN NECROSIS 51 0.0098
217 HEREDITARY ANGIOEDEMA 105 0.0098
218 LIMB INJURY 264 0.0097
219 GINGIVITIS 52 0.0096
220 PRODUCTIVE COUGH 460 0.0096
221 ROTATOR CUFF SYNDROME 123 0.0096
222 VAGINAL INFECTION 45 0.0096
223 STAPHYLOCOCCAL SEPSIS 47 0.0095
224 INJECTION SITE DISCHARGE 51 0.0095
225 NERVE INJURY 105 0.0094
226 CARDIOTOXICITY 84 0.0094
227 RESPIRATORY TRACT CONGESTION 147 0.0092
228 MUSCLE STRAIN 80 0.0092
229 SENSITIVE SKIN 68 0.0092
230 APPLICATION SITE PAIN 203 0.0092
231 LIGAMENT SPRAIN 91 0.0092
232 ACUTE RESPIRATORY FAILURE 177 0.0092
233 VEIN DISORDER 46 0.0092
234 HAEMORRHOIDS 179 0.0092
235 HAND FRACTURE 65 0.0092
236 ORAL CANDIDIASIS 120 0.0091
237 SCIATICA 145 0.0091
238 FIBROMYALGIA 221 0.0091
239 APPLICATION SITE IRRITATION 113 0.0091
240 FOOT FRACTURE 172 0.0091
241 RENAL FAILURE 1202 0.0090
242 POSTOPERATIVE WOUND INFECTION 61 0.0090
243 SINUS CONGESTION 122 0.0090
244 NERVE COMPRESSION 83 0.0090
245 UPPER-AIRWAY COUGH SYNDROME 74 0.0090
246 MUSCULOSKELETAL CHEST PAIN 139 0.0090
247 ATRIOVENTRICULAR BLOCK COMPLETE 60 0.0090
248 IMPAIRED GASTRIC EMPTYING 122 0.0089
249 INJURY 629 0.0089
250 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 465 0.0089
251 HYPERAESTHESIA 73 0.0089
252 SUPRAVENTRICULAR TACHYCARDIA 85 0.0089
253 ECONOMIC PROBLEM 134 0.0088
254 LYMPHOEDEMA 61 0.0088
255 RENAL TUBULAR NECROSIS 86 0.0088
256 FACIAL PAIN 78 0.0087
257 ACUTE PULMONARY OEDEMA 49 0.0087
258 HIATUS HERNIA 113 0.0087
259 EXOSTOSIS 79 0.0086
260 OSTEOMYELITIS 156 0.0086
261 FUNGAL INFECTION 286 0.0086
262 IRON DEFICIENCY ANAEMIA 79 0.0085
263 AUTOIMMUNE DISORDER 83 0.0085
264 MIOSIS 68 0.0085
265 PRODUCT AVAILABILITY ISSUE 192 0.0084
266 HYPOTENSION 1686 0.0084
267 COMPRESSION FRACTURE 45 0.0084
268 PNEUMONIA BACTERIAL 77 0.0084
269 TACHYPNOEA 114 0.0084
270 SPINAL OPERATION 103 0.0084
271 GRAND MAL CONVULSION 77 0.0083
272 FACIAL PARALYSIS 71 0.0083
273 BEHAVIOUR DISORDER 45 0.0083
274 ECCHYMOSIS 57 0.0083
275 INADEQUATE ANALGESIA 70 0.0082
276 RENAL CYST 65 0.0082
277 INFLUENZA 912 0.0082
278 THERMAL BURN 58 0.0082
279 SLEEP APNOEA SYNDROME 155 0.0081
280 CLOSTRIDIUM DIFFICILE COLITIS 86 0.0081
281 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 44 0.0081
282 SKIN WARM 47 0.0081
283 DRUG LEVEL INCREASED 133 0.0080
284 SPINAL PAIN 94 0.0080
285 TACHYCARDIA 712 0.0080
286 THERAPY PARTIAL RESPONDER 125 0.0080
287 ANAL INCONTINENCE 72 0.0080
288 CARPAL TUNNEL SYNDROME 112 0.0080
289 BODY TEMPERATURE INCREASED 162 0.0079
290 VITREOUS FLOATERS 78 0.0079
291 PLEURISY 47 0.0079
292 PNEUMOTHORAX 125 0.0079
293 ULCER 125 0.0078
294 JOINT INJURY 167 0.0078
295 RHINITIS 63 0.0078
296 OXYGEN SATURATION DECREASED 439 0.0078
297 PRODUCT DOSE OMISSION ISSUE 2296 0.0078
298 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1407 0.0078
299 HYPERKERATOSIS 43 0.0078
300 BRAIN FOG 122 0.0078
301 INTERVERTEBRAL DISC PROTRUSION 169 0.0077
302 MASS 108 0.0077
303 PULMONARY MASS 115 0.0077
304 SMALL INTESTINAL OBSTRUCTION 95 0.0077
305 JOINT EFFUSION 53 0.0077
306 WOUND INFECTION 84 0.0077
307 MUSCULOSKELETAL DISCOMFORT 132 0.0077
308 BURSITIS 93 0.0077
309 MULTIPLE ORGAN DYSFUNCTION SYNDROME 217 0.0077
310 FEBRILE NEUTROPENIA 508 0.0077
311 CARDIOMEGALY 94 0.0076
312 NECK PAIN 427 0.0076
313 CYANOSIS 120 0.0076
314 DIVERTICULITIS 211 0.0076
315 UNEVALUABLE EVENT 575 0.0076
316 BLOOD PRESSURE ABNORMAL 151 0.0076
317 HERPES ZOSTER 436 0.0076
318 SCOLIOSIS 47 0.0076
319 PNEUMONIA 2456 0.0076
320 DIPLOPIA 197 0.0076
321 RETINAL HAEMORRHAGE 54 0.0076
322 GOUT 136 0.0076
323 EYELID PTOSIS 77 0.0076
324 FLANK PAIN 71 0.0076
325 TOXICITY TO VARIOUS AGENTS 1276 0.0076
326 PARAESTHESIA ORAL 109 0.0075
327 OSTEOPENIA 114 0.0075
328 MIGRAINE 716 0.0075
329 INCONTINENCE 79 0.0075
330 CLOSTRIDIUM DIFFICILE INFECTION 163 0.0075
331 OBSTRUCTIVE AIRWAYS DISORDER 83 0.0075
332 RESPIRATORY DISTRESS 205 0.0074
333 EAR PAIN 144 0.0074
334 SINUS HEADACHE 44 0.0074
335 ASPIRATION 81 0.0074
336 VITAMIN D DEFICIENCY 72 0.0074
337 NASOPHARYNGITIS 1344 0.0073
338 DRUG TOXICITY 99 0.0073
339 PHARYNGEAL SWELLING 71 0.0072
340 RESPIRATION ABNORMAL 50 0.0072
341 MALNUTRITION 81 0.0072
342 SEPSIS 806 0.0072
343 DYSARTHRIA 271 0.0072
344 JOINT DISLOCATION 76 0.0072
345 POST-TRAUMATIC STRESS DISORDER 48 0.0072
346 DEVICE RELATED INFECTION 110 0.0071
347 SPINAL COMPRESSION FRACTURE 59 0.0071
348 ENCEPHALOPATHY 175 0.0071
349 APPLICATION SITE VESICLES 46 0.0071
350 BACK INJURY 77 0.0071
351 BLOOD CALCIUM INCREASED 62 0.0071
352 APPLICATION SITE ERYTHEMA 185 0.0071
353 CONTUSION 678 0.0070
354 ACCIDENT 84 0.0070
355 PNEUMONIA ASPIRATION 175 0.0070
356 INFECTION 1013 0.0070
357 PROCEDURAL PAIN 194 0.0070
358 WALKING AID USER 46 0.0070
359 IMPAIRED QUALITY OF LIFE 100 0.0069
360 PULMONARY CONGESTION 91 0.0069
361 SEROTONIN SYNDROME 132 0.0069
362 SPINAL DISORDER 65 0.0069
363 SPUTUM DISCOLOURED 65 0.0068
364 PREMATURE DELIVERY 109 0.0068
365 NEPHROLITHIASIS 313 0.0068
366 OEDEMA 370 0.0068
367 ORAL DISORDER 50 0.0068
368 WRONG PRODUCT ADMINISTERED 46 0.0068
369 POOR QUALITY SLEEP 145 0.0067
370 BLOOD PRESSURE DECREASED 446 0.0067
371 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 52 0.0067
372 CONJUNCTIVITIS 124 0.0067
373 THERAPY NON-RESPONDER 300 0.0067
374 BACTERAEMIA 79 0.0066
375 ANKLE FRACTURE 103 0.0066
376 BACK DISORDER 108 0.0066
377 LOWER RESPIRATORY TRACT INFECTION 302 0.0066
378 NEPHROPATHY 62 0.0066
379 HYPERCHOLESTEROLAEMIA 64 0.0066
380 DIVERTICULUM 47 0.0066
381 PLEURAL EFFUSION 402 0.0066
382 HAEMATOCRIT DECREASED 131 0.0066
383 SPINAL FRACTURE 132 0.0066
384 PULMONARY OEDEMA 295 0.0066
385 BACK PAIN 1527 0.0066
386 HYPOALBUMINAEMIA 51 0.0066
387 TRICUSPID VALVE INCOMPETENCE 52 0.0065
388 RESPIRATORY FAILURE 475 0.0065
389 BLOOD IRON DECREASED 77 0.0065
390 BRAIN INJURY 65 0.0065
391 MOTOR DYSFUNCTION 66 0.0065
392 LUNG INFILTRATION 57 0.0064
393 CHILLS 756 0.0064
394 APHTHOUS ULCER 50 0.0064
395 BLADDER DISORDER 64 0.0064
396 ORAL PAIN 144 0.0064
397 WRIST FRACTURE 77 0.0064
398 SKIN ULCER 166 0.0064
399 PELVIC FRACTURE 50 0.0064
400 RESPIRATORY DISORDER 192 0.0064
401 UROSEPSIS 59 0.0064
402 HOSPICE CARE 63 0.0064
403 OSTEOPOROSIS 262 0.0064
404 DELIRIUM 221 0.0064
405 ASCITES 187 0.0064
406 HEAD INJURY 201 0.0063
407 CYTOKINE RELEASE SYNDROME 127 0.0063
408 ABSCESS 101 0.0063
409 RESPIRATORY ARREST 174 0.0063
410 APHONIA 88 0.0063
411 BLOOD ALBUMIN DECREASED 50 0.0063
412 CARDIO-RESPIRATORY ARREST 262 0.0063
413 SHOCK 144 0.0063
414 EMPHYSEMA 63 0.0062
415 TOOTHACHE 113 0.0062
416 MICTURITION URGENCY 71 0.0062
417 PULMONARY HYPERTENSION 129 0.0062
418 MITRAL VALVE INCOMPETENCE 70 0.0062
419 SEIZURE 713 0.0062
420 OROPHARYNGEAL PAIN 571 0.0062
421 EXTRASYSTOLES 43 0.0062
422 SWELLING 576 0.0061
423 PARALYSIS 88 0.0061
424 BLOOD MAGNESIUM DECREASED 53 0.0061
425 NODULE 80 0.0061
426 DYSPNOEA EXERTIONAL 229 0.0061
427 FALL 2021 0.0061
428 TOOTH DISORDER 135 0.0061
429 ATAXIA 72 0.0061
430 ORAL HERPES 118 0.0060
431 ACUTE KIDNEY INJURY 925 0.0060
432 PAIN 3709 0.0060
433 UPPER LIMB FRACTURE 120 0.0060
434 LEUKOCYTOSIS 109 0.0060
435 DISABILITY 119 0.0060
436 PAIN IN JAW 170 0.0060
437 ELECTROCARDIOGRAM QT PROLONGED 215 0.0060
438 DENTAL CARIES 66 0.0060
439 JOINT RANGE OF MOTION DECREASED 80 0.0060
440 PULMONARY THROMBOSIS 65 0.0060
441 ATRIAL FIBRILLATION 580 0.0059
442 OSTEOARTHRITIS 252 0.0059
443 GROIN PAIN 52 0.0059
444 LOW BIRTH WEIGHT BABY 47 0.0059
445 METABOLIC ACIDOSIS 189 0.0059
446 ATRIAL FLUTTER 47 0.0059
447 CATARACT 350 0.0059
448 BLOOD CALCIUM DECREASED 66 0.0059
449 OROPHARYNGEAL DISCOMFORT 53 0.0059
450 LUNG INFECTION 91 0.0059
451 BLOOD POTASSIUM DECREASED 176 0.0058
452 LYMPHADENOPATHY 207 0.0058
453 BLOOD PRESSURE DIASTOLIC DECREASED 43 0.0058
454 INCORRECT PRODUCT ADMINISTRATION DURATION 126 0.0058
455 IRRITABLE BOWEL SYNDROME 123 0.0057
456 HEART RATE DECREASED 201 0.0057
457 RENAL FAILURE CHRONIC 44 0.0057
458 EXPIRED PRODUCT ADMINISTERED 190 0.0057
459 TOOTH FRACTURE 63 0.0057
460 HEPATOMEGALY 56 0.0057
461 ATRIOVENTRICULAR BLOCK 44 0.0057
462 GASTROOESOPHAGEAL REFLUX DISEASE 458 0.0057
463 DEPRESSED LEVEL OF CONSCIOUSNESS 225 0.0057
464 FOOT DEFORMITY 63 0.0057
465 PREMATURE BABY 171 0.0057
466 PYELONEPHRITIS 49 0.0056
467 NASAL CONGESTION 332 0.0056
468 CYST 70 0.0056
469 ARTERIOSCLEROSIS 53 0.0056
470 COUGH 1572 0.0056
471 MUSCLE RIGIDITY 67 0.0056
472 HAEMATOMA 145 0.0056
473 LOSS OF CONSCIOUSNESS 716 0.0056
474 LETHARGY 321 0.0056
475 APPLICATION SITE PRURITUS 126 0.0055
476 MUSCLE TWITCHING 128 0.0055
477 HYPOKALAEMIA 256 0.0055
478 ROAD TRAFFIC ACCIDENT 231 0.0055
479 HAEMOPTYSIS 154 0.0055
480 PYREXIA 1910 0.0055
481 SCRATCH 58 0.0055
482 BLOOD UREA INCREASED 92 0.0055
483 MUSCLE TIGHTNESS 89 0.0055
484 ANXIETY 1560 0.0055
485 EJECTION FRACTION DECREASED 85 0.0055
486 NEEDLE ISSUE 159 0.0055
487 EYE INFLAMMATION 52 0.0054
488 COMPLICATION ASSOCIATED WITH DEVICE 79 0.0054
489 BLOOD PRESSURE INCREASED 830 0.0054
490 ELECTROLYTE IMBALANCE 63 0.0054
491 RENAL FAILURE ACUTE 229 0.0054
492 COLD SWEAT 95 0.0054
493 TUBULOINTERSTITIAL NEPHRITIS 101 0.0054
494 NEUTROPHIL COUNT INCREASED 55 0.0054
495 HEADACHE 3367 0.0054
496 CARDIOMYOPATHY 79 0.0053
497 NEUROPATHY PERIPHERAL 506 0.0053
498 HEMIPARESIS 90 0.0053
499 ACUTE CORONARY SYNDROME 44 0.0053
500 PURPURA 47 0.0053
501 HYPERTENSIVE CRISIS 59 0.0053
502 URINARY INCONTINENCE 157 0.0053
503 BONE DISORDER 96 0.0053
504 PRODUCT USE IN UNAPPROVED INDICATION 1305 0.0053
505 DIZZINESS POSTURAL 51 0.0053
506 OCULAR DISCOMFORT 59 0.0053
507 BLOOD SODIUM DECREASED 99 0.0052
508 HYPOMAGNESAEMIA 73 0.0052
509 LIMB DISCOMFORT 162 0.0052
510 ILEUS 65 0.0052
511 INTENTIONAL PRODUCT USE ISSUE 458 0.0052
512 HERNIA 101 0.0052
513 RETINAL DETACHMENT 48 0.0052
514 OESOPHAGITIS 57 0.0052
515 URINARY RETENTION 174 0.0052
516 ASTHMA 589 0.0052
517 LOWER LIMB FRACTURE 100 0.0052
518 DISCOMFORT 317 0.0052
519 STOMATITIS 315 0.0052
520 MYOCARDIAL ISCHAEMIA 59 0.0052
521 GENERALISED OEDEMA 64 0.0052
522 RESTLESS LEGS SYNDROME 94 0.0052
523 WHEEZING 306 0.0052
524 HYPERTENSION 1093 0.0052
525 PHOTOPHOBIA 97 0.0052
526 POST PROCEDURAL HAEMORRHAGE 60 0.0051
527 PALLOR 140 0.0051
528 BASAL CELL CARCINOMA 80 0.0051
529 MYOSITIS 46 0.0051
530 HYPONATRAEMIA 288 0.0051
531 GASTROINTESTINAL DISORDER 457 0.0051
532 LYMPHOCYTE COUNT DECREASED 90 0.0051
533 INFLUENZA LIKE ILLNESS 419 0.0051
534 CARDIAC MURMUR 44 0.0051
535 DRUG INTERACTION 806 0.0051
536 WOUND 142 0.0051
537 RESPIRATORY RATE INCREASED 45 0.0051
538 THYROID DISORDER 78 0.0051
539 BLOOD URINE PRESENT 96 0.0051
540 ABDOMINAL DISTENSION 527 0.0050
541 THROMBOSIS 406 0.0050
542 DEHYDRATION 673 0.0050
543 ACCIDENTAL OVERDOSE 184 0.0050
544 HYPOTONIA 50 0.0050
545 DERMATITIS ALLERGIC 63 0.0050
546 INCREASED TENDENCY TO BRUISE 46 0.0050
547 TINNITUS 229 0.0050
548 ARTHRITIS 389 0.0049
549 EMOTIONAL DISTRESS 598 0.0049
550 COMA 235 0.0049
551 BLOOD TEST ABNORMAL 69 0.0049
552 RENAL PAIN 52 0.0049
553 PRESYNCOPE 119 0.0049
554 HEART RATE INCREASED 483 0.0049
555 COAGULOPATHY 81 0.0049
556 HYPERKALAEMIA 170 0.0048
557 CHEST DISCOMFORT 496 0.0048
558 HYPOAESTHESIA 724 0.0048
559 DEVICE OCCLUSION 68 0.0048
560 WEIGHT DECREASED 1347 0.0048
561 BURNING SENSATION 338 0.0048
562 SUBARACHNOID HAEMORRHAGE 49 0.0048
563 PERIPHERAL SWELLING 741 0.0048
564 DYSURIA 177 0.0048
565 OFF LABEL USE 4206 0.0048
566 APHASIA 145 0.0048
567 LIVER FUNCTION TEST INCREASED 103 0.0048
568 HALLUCINATION, VISUAL 101 0.0048
569 FLUID RETENTION 243 0.0048
570 MUCOSAL INFLAMMATION 125 0.0048
571 SWOLLEN TONGUE 149 0.0048
572 CONSTIPATION 1039 0.0048
573 EXPOSURE DURING PREGNANCY 296 0.0048
574 HYPOTHYROIDISM 152 0.0048
575 DISSEMINATED INTRAVASCULAR COAGULATION 67 0.0048
576 SEPTIC SHOCK 207 0.0048
577 SKIN DISCOLOURATION 218 0.0047
578 CHROMATURIA 107 0.0047
579 FULL BLOOD COUNT ABNORMAL 50 0.0047
580 PRODUCT USE ISSUE 886 0.0047
581 TRANSIENT ISCHAEMIC ATTACK 159 0.0047
582 RESTLESSNESS 172 0.0047
583 NEOPLASM 54 0.0047
584 PRODUCT DOSE OMISSION IN ERROR 133 0.0047
585 QUALITY OF LIFE DECREASED 63 0.0047
586 SARS-COV-2 TEST POSITIVE 62 0.0047
587 LUNG DISORDER 230 0.0047
588 RHINORRHOEA 303 0.0047
589 RED BLOOD CELL COUNT DECREASED 134 0.0047
590 RENAL IMPAIRMENT 391 0.0046
591 TENDONITIS 72 0.0046
592 MUSCULAR WEAKNESS 527 0.0046
593 ANGIOEDEMA 205 0.0046
594 CHEST PAIN 858 0.0046
595 VERTIGO 282 0.0046
596 INJECTION SITE EXTRAVASATION 57 0.0046
597 TENDON RUPTURE 57 0.0046
598 INTRAOCULAR PRESSURE INCREASED 59 0.0046
599 TOXIC EPIDERMAL NECROLYSIS 70 0.0046
600 FATIGUE 3575 0.0046
601 EPISTAXIS 343 0.0046
602 EAR DISCOMFORT 47 0.0046
603 SOMNOLENCE 918 0.0046
604 BLOOD POTASSIUM INCREASED 74 0.0046
605 EYE PAIN 257 0.0046
606 CONFUSIONAL STATE 736 0.0045
607 SECRETION DISCHARGE 57 0.0045
608 SLEEP DISORDER 321 0.0045
609 NERVOUS SYSTEM DISORDER 141 0.0045
610 HEART RATE IRREGULAR 102 0.0045
611 EATING DISORDER 96 0.0045
612 SPEECH DISORDER 236 0.0045
613 SYNCOPE 450 0.0045
614 BLISTER 252 0.0045
615 WHITE BLOOD CELL COUNT INCREASED 172 0.0045
616 DYSPHONIA 262 0.0045
617 DYSPHAGIA 425 0.0045
618 IMPAIRED HEALING 147 0.0045
619 BLOOD CHOLESTEROL INCREASED 208 0.0045
620 COLITIS 169 0.0045
621 MATERNAL EXPOSURE DURING PREGNANCY 397 0.0044
622 VOMITING 2093 0.0044
623 DRY MOUTH 361 0.0044
624 DYSTONIA 86 0.0044
625 PAIN IN EXTREMITY 1306 0.0044
626 OEDEMA PERIPHERAL 540 0.0044
627 GLAUCOMA 85 0.0044
628 ACUTE RESPIRATORY DISTRESS SYNDROME 78 0.0044
629 PETECHIAE 46 0.0044
630 PRODUCT ADMINISTRATION ERROR 89 0.0044
631 VISUAL ACUITY REDUCED 146 0.0044
632 TRANSFUSION 46 0.0044
633 SCAB 50 0.0044
634 ANAEMIA 836 0.0044
635 FEELING COLD 122 0.0044
636 NAUSEA 3465 0.0044
637 NIGHT SWEATS 141 0.0044
638 MUSCULOSKELETAL PAIN 229 0.0044
639 MOUTH ULCERATION 92 0.0044
640 PULMONARY EMBOLISM 414 0.0044
641 HIP FRACTURE 140 0.0043
642 SKIN DISORDER 145 0.0043
643 TOOTH EXTRACTION 54 0.0043
644 DYSPNOEA 2455 0.0043
645 SKIN REACTION 61 0.0043
646 SNEEZING 97 0.0043
647 AGITATION 317 0.0043
648 URTICARIA 720 0.0043
649 LIP SWELLING 143 0.0043
650 TASTE DISORDER 87 0.0043
651 ARRHYTHMIA 203 0.0043
652 PERICARDIAL EFFUSION 99 0.0043
653 RETCHING 91 0.0043
654 GALLBLADDER DISORDER 76 0.0043
655 BLOOD PRESSURE FLUCTUATION 102 0.0042
656 HEPATIC STEATOSIS 79 0.0042
657 EYE DISCHARGE 44 0.0042
658 DYSKINESIA 171 0.0042
659 ADRENAL INSUFFICIENCY 51 0.0042
660 CHOLECYSTECTOMY 48 0.0042
661 GAIT INABILITY 140 0.0042
662 TREMOR 695 0.0042
663 MACULAR DEGENERATION 50 0.0042
664 HEAD DISCOMFORT 74 0.0042
665 BLINDNESS 170 0.0042
666 ACUTE MYOCARDIAL INFARCTION 123 0.0042
667 MUSCLE SPASMS 765 0.0042
668 BALANCE DISORDER 360 0.0042
669 MENTAL DISORDER 181 0.0042
670 MUSCLE SPASTICITY 51 0.0041
671 GASTRITIS 109 0.0041
672 SKIN CANCER 89 0.0041
673 CHOLELITHIASIS 135 0.0041
674 SURGERY 241 0.0041
675 BEDRIDDEN 54 0.0041
676 SWELLING FACE 267 0.0041
677 HYPERSOMNIA 117 0.0041
678 PULMONARY FIBROSIS 78 0.0041
679 SKIN LESION 111 0.0040
680 PREGNANCY 81 0.0040
681 DYSSTASIA 118 0.0040
682 ERYTHEMA 828 0.0040
683 HAIR COLOUR CHANGES 50 0.0040
684 MUSCULOSKELETAL STIFFNESS 351 0.0040
685 PARAESTHESIA 629 0.0040
686 THROAT TIGHTNESS 108 0.0040
687 DRUG INTOLERANCE 385 0.0040
688 FACE OEDEMA 67 0.0040
689 DISORIENTATION 157 0.0040
690 DECREASED APPETITE 919 0.0040
691 BLOOD PRESSURE SYSTOLIC INCREASED 77 0.0039
692 PRODUCT PRESCRIBING ISSUE 86 0.0039
693 CHOLECYSTITIS 47 0.0039
694 DEEP VEIN THROMBOSIS 256 0.0039
695 PRODUCT USE COMPLAINT 62 0.0039
696 HYPOKINESIA 57 0.0039
697 NO ADVERSE EVENT 710 0.0039
698 DERMATITIS 82 0.0039
699 INTENTIONAL DOSE OMISSION 111 0.0039
700 DIZZINESS 1936 0.0039
701 PHOTOSENSITIVITY REACTION 64 0.0039
702 FULL BLOOD COUNT DECREASED 78 0.0039
703 IMMUNE SYSTEM DISORDER 51 0.0039
704 ABDOMINAL PAIN 900 0.0039
705 HIP ARTHROPLASTY 59 0.0038
706 HYPERHIDROSIS 496 0.0038
707 DRUG EFFECT LESS THAN EXPECTED 57 0.0038
708 RASH PRURITIC 208 0.0038
709 HYPERSENSITIVITY 712 0.0038
710 ALTERED STATE OF CONSCIOUSNESS 83 0.0038
711 PERICARDITIS 64 0.0038
712 PULMONARY ARTERIAL HYPERTENSION 55 0.0038
713 RECTAL HAEMORRHAGE 163 0.0038
714 MUSCLE ATROPHY 48 0.0038
715 PERIPHERAL COLDNESS 52 0.0038
716 ARTHROPATHY 210 0.0038
717 GAIT DISTURBANCE 723 0.0038
718 HAEMATURIA 129 0.0038
719 THROAT IRRITATION 169 0.0038
720 FEEDING DISORDER 76 0.0037
721 RENAL DISORDER 174 0.0037
722 DIABETES MELLITUS 284 0.0037
723 INTENTIONAL PRODUCT MISUSE 326 0.0037
724 MEDICATION ERROR 206 0.0037
725 COGNITIVE DISORDER 173 0.0037
726 SEDATION 97 0.0037
727 OBESITY 59 0.0037
728 MALAISE 1620 0.0037
729 ARTHRALGIA 1534 0.0037
730 ASTHENIA 1386 0.0037
731 DEPRESSION 837 0.0037
732 BONE PAIN 215 0.0037
733 GINGIVAL BLEEDING 50 0.0037
734 RASH 1595 0.0037
735 PALPITATIONS 428 0.0037
736 BONE DENSITY DECREASED 114 0.0036
737 ASPARTATE AMINOTRANSFERASE INCREASED 193 0.0036
738 MENTAL IMPAIRMENT 88 0.0036
739 C-REACTIVE PROTEIN INCREASED 131 0.0036
740 RASH MACULO-PAPULAR 80 0.0036
741 JOINT STIFFNESS 94 0.0036
742 POISONING 45 0.0036
743 WEIGHT INCREASED 802 0.0036
744 GASTRIC ULCER 68 0.0036
745 CORONARY ARTERY DISEASE 108 0.0036
746 PNEUMONITIS 97 0.0036
747 HAEMOGLOBIN DECREASED 362 0.0035
748 HALLUCINATION 265 0.0035
749 HAIR TEXTURE ABNORMAL 47 0.0035
750 CARDIAC DISORDER 328 0.0035
751 AMNESIA 228 0.0035
752 BLOOD ALKALINE PHOSPHATASE INCREASED 87 0.0035
753 PANCYTOPENIA 195 0.0035
754 DEAFNESS 91 0.0035
755 RASH PAPULAR 78 0.0035
756 INTESTINAL OBSTRUCTION 131 0.0035
757 LACRIMATION INCREASED 105 0.0035
758 METASTASES TO BONE 57 0.0035
759 INFLAMMATION 179 0.0035
760 VISION BLURRED 476 0.0035
761 BLOOD BILIRUBIN INCREASED 93 0.0034
762 DIARRHOEA 2217 0.0034
763 CARDIAC FAILURE CONGESTIVE 275 0.0034
764 METASTASES TO CENTRAL NERVOUS SYSTEM 44 0.0034
765 PRODUCT PREPARATION ERROR 70 0.0034
766 POLLAKIURIA 142 0.0034
767 RASH MACULAR 119 0.0034
768 BLOOD TRIGLYCERIDES INCREASED 60 0.0034
769 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 163 0.0034
770 FEELING HOT 208 0.0034
771 HYPERTHYROIDISM 49 0.0034
772 HYPOPHAGIA 86 0.0034
773 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 239 0.0034
774 CONVULSION 192 0.0034
775 DRUG INEFFECTIVE 4423 0.0034
776 CENTRAL NERVOUS SYSTEM LESION 46 0.0033
777 DRUG ABUSE 278 0.0033
778 ACTIVITIES OF DAILY LIVING IMPAIRED 66 0.0033
779 ORTHOSTATIC HYPOTENSION 58 0.0033
780 PSYCHOMOTOR HYPERACTIVITY 55 0.0033
781 MOBILITY DECREASED 238 0.0033
782 MEMORY IMPAIRMENT 455 0.0033
783 BLOOD CREATININE INCREASED 216 0.0033
784 RASH ERYTHEMATOUS 158 0.0033
785 SENSORY DISTURBANCE 53 0.0033
786 PRURITUS 1269 0.0033
787 FLUID OVERLOAD 48 0.0033
788 FLUSHING 335 0.0033
789 DRY EYE 164 0.0033
790 HAEMORRHAGE 343 0.0033
791 DISTURBANCE IN ATTENTION 176 0.0033
792 INSOMNIA 867 0.0033
793 NERVOUSNESS 170 0.0033
794 PARANOIA 56 0.0032
795 HEPATIC CIRRHOSIS 61 0.0032
796 EYE HAEMORRHAGE 43 0.0032
797 PLATELET COUNT DECREASED 343 0.0032
798 FEELING ABNORMAL 770 0.0032
799 TREATMENT FAILURE 265 0.0032
800 DYSPEPSIA 314 0.0032
801 IMPAIRED WORK ABILITY 68 0.0032
802 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 644 0.0032
803 ABDOMINAL DISCOMFORT 533 0.0032
804 JOINT SWELLING 383 0.0032
805 SYSTEMIC LUPUS ERYTHEMATOSUS 112 0.0032
806 IMMUNODEFICIENCY 47 0.0031
807 STEVENS-JOHNSON SYNDROME 70 0.0031
808 CONDITION AGGRAVATED 957 0.0031
809 ALANINE AMINOTRANSFERASE INCREASED 193 0.0031
810 TOOTH LOSS 65 0.0031
811 PRODUCT PHYSICAL ISSUE 63 0.0031
812 OSTEONECROSIS OF JAW 77 0.0031
813 MYALGIA 529 0.0031
814 MULTIPLE FRACTURES 51 0.0031
815 GENERAL PHYSICAL HEALTH DETERIORATION 359 0.0031
816 KNEE ARTHROPLASTY 65 0.0031
817 COORDINATION ABNORMAL 43 0.0031
818 SUBDURAL HAEMATOMA 44 0.0031
819 ANGINA PECTORIS 88 0.0031
820 LYMPHOMA 47 0.0030
821 THROMBOCYTOPENIA 339 0.0030
822 DIALYSIS 43 0.0030
823 ABDOMINAL PAIN UPPER 622 0.0030
824 PANIC ATTACK 110 0.0030
825 OSTEONECROSIS 99 0.0030
826 CARDIAC FAILURE 241 0.0030
827 OVERDOSE 645 0.0030
828 CEREBROVASCULAR ACCIDENT 504 0.0030
829 PELVIC PAIN 54 0.0030
830 THERAPY INTERRUPTED 212 0.0030
831 EYE DISORDER 97 0.0029
832 PLASMA CELL MYELOMA 115 0.0029
833 NEUTROPHIL COUNT DECREASED 120 0.0029
834 INCORRECT ROUTE OF DRUG ADMINISTRATION 105 0.0029
835 HYPOCALCAEMIA 55 0.0029
836 VISUAL IMPAIRMENT 359 0.0029
837 WHITE BLOOD CELL COUNT DECREASED 312 0.0029
838 FLATULENCE 162 0.0029
839 PRESCRIBED OVERDOSE 55 0.0028
840 HAEMATEMESIS 72 0.0028
841 MIDDLE INSOMNIA 53 0.0028
842 HYPOACUSIS 122 0.0028
843 DELUSION 44 0.0028
844 HOT FLUSH 213 0.0028
845 HEPATIC FAILURE 85 0.0028
846 CEREBRAL HAEMORRHAGE 100 0.0028
847 RHEUMATOID ARTHRITIS 316 0.0028
848 NEUTROPENIA 377 0.0028
849 THERAPEUTIC RESPONSE UNEXPECTED 124 0.0028
850 LIVER DISORDER 122 0.0027
851 ADVERSE DRUG REACTION 247 0.0027
852 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64 0.0027
853 TRANSAMINASES INCREASED 61 0.0027
854 FAECES DISCOLOURED 59 0.0027
855 CHOKING 53 0.0027
856 EYE SWELLING 101 0.0027
857 MOVEMENT DISORDER 87 0.0027
858 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 46 0.0027
859 INJECTION SITE SWELLING 206 0.0027
860 SKIN IRRITATION 123 0.0027
861 DEMENTIA 75 0.0027
862 EOSINOPHILIA 47 0.0027
863 FEELING JITTERY 51 0.0027
864 OCULAR HYPERAEMIA 127 0.0027
865 FOETAL EXPOSURE DURING PREGNANCY 217 0.0027
866 CRYING 97 0.0027
867 AGEUSIA 66 0.0026
868 GASTROINTESTINAL HAEMORRHAGE 221 0.0026
869 THERAPEUTIC PRODUCT EFFECT DECREASED 118 0.0026
870 HYPERGLYCAEMIA 96 0.0026
871 INJECTION SITE MASS 96 0.0026
872 DRUG ERUPTION 46 0.0026
873 INTERNATIONAL NORMALISED RATIO INCREASED 74 0.0026
874 NEOPLASM MALIGNANT 173 0.0026
875 THIRST 46 0.0026
876 MUSCULOSKELETAL DISORDER 49 0.0026
877 HOSPITALISATION 394 0.0026
878 ECZEMA 134 0.0026
879 SUICIDAL IDEATION 234 0.0026
880 GLOSSODYNIA 57 0.0025
881 ALOPECIA 494 0.0025
882 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 46 0.0025
883 SKIN FISSURES 49 0.0025
884 GASTRIC DISORDER 86 0.0025
885 DYSGEUSIA 185 0.0025
886 HAEMATOCHEZIA 136 0.0025
887 NEOPLASM PROGRESSION 85 0.0024
888 SYNOVITIS 44 0.0024
889 DISEASE PROGRESSION 288 0.0024
890 DEPRESSED MOOD 128 0.0024
891 INTENTIONAL OVERDOSE 155 0.0024
892 BLOOD GLUCOSE DECREASED 116 0.0024
893 THINKING ABNORMAL 45 0.0024
894 DRUG EFFECT DECREASED 130 0.0024
895 ABDOMINAL PAIN LOWER 61 0.0024
896 ISCHAEMIC STROKE 43 0.0024
897 EMOTIONAL DISORDER 74 0.0024
898 EPILEPSY 73 0.0024
899 TYPE 2 DIABETES MELLITUS 80 0.0024
900 SKIN EXFOLIATION 200 0.0024
901 PROTEINURIA 45 0.0024
902 PSORIATIC ARTHROPATHY 96 0.0024
903 WITHDRAWAL SYNDROME 98 0.0023
904 MALIGNANT NEOPLASM PROGRESSION 237 0.0023
905 HYPOGLYCAEMIA 112 0.0023
906 PSYCHOTIC DISORDER 68 0.0023
907 RHABDOMYOLYSIS 96 0.0023
908 INJECTION SITE PRURITUS 154 0.0023
909 EYE IRRITATION 132 0.0023
910 DEVICE DISLOCATION 99 0.0023
911 THERAPEUTIC RESPONSE DECREASED 138 0.0023
912 INCORRECT DRUG ADMINISTRATION DURATION 64 0.0023
913 MELAENA 50 0.0023
914 INJECTION SITE ERYTHEMA 281 0.0023
915 ILL-DEFINED DISORDER 137 0.0023
916 TREATMENT NONCOMPLIANCE 123 0.0022
917 INJECTION SITE PAIN 688 0.0022
918 MOOD ALTERED 60 0.0022
919 LACTIC ACIDOSIS 71 0.0022
920 BLOOD CREATINE PHOSPHOKINASE INCREASED 63 0.0022
921 HEPATIC ENZYME INCREASED 149 0.0022
922 PANCREATITIS 115 0.0022
923 DRUG EFFECT INCOMPLETE 78 0.0021
924 FREQUENT BOWEL MOVEMENTS 58 0.0021
925 THERAPEUTIC RESPONSE SHORTENED 71 0.0021
926 DEATH 1844 0.0021
927 LABORATORY TEST ABNORMAL 63 0.0021
928 RASH GENERALISED 55 0.0021
929 EYE PRURITUS 71 0.0021
930 IRRITABILITY 127 0.0021
931 INJECTION SITE WARMTH 43 0.0021
932 FEMUR FRACTURE 64 0.0021
933 NIGHTMARE 71 0.0020
934 CARDIOVASCULAR DISORDER 52 0.0020
935 INCORRECT DOSE ADMINISTERED 465 0.0020
936 PRURITUS GENERALISED 44 0.0020
937 PRODUCT DOSE OMISSION 132 0.0020
938 DRUG ADMINISTRATION ERROR 61 0.0020
939 MULTIPLE SCLEROSIS 95 0.0020
940 INJECTION SITE BRUISING 158 0.0020
941 PRODUCT SUBSTITUTION ISSUE 114 0.0020
942 AGGRESSION 99 0.0020
943 DRY SKIN 264 0.0020
944 EXTRAPYRAMIDAL DISORDER 49 0.0020
945 MYOCARDIAL INFARCTION 344 0.0020
946 CEREBRAL INFARCTION 48 0.0020
947 DEVICE ISSUE 176 0.0020
948 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 57 0.0019
949 LEUKOPENIA 97 0.0019
950 INJECTION SITE REACTION 132 0.0019
951 CONTRAINDICATED PRODUCT ADMINISTERED 57 0.0019
952 LIVER INJURY 46 0.0019
953 WRONG TECHNIQUE IN DRUG USAGE PROCESS 68 0.0019
954 DEVICE LEAKAGE 80 0.0018
955 PAIN OF SKIN 49 0.0018
956 HEPATIC FUNCTION ABNORMAL 66 0.0018
957 HEPATITIS 45 0.0018
958 VAGINAL HAEMORRHAGE 73 0.0017
959 ADVERSE EVENT 152 0.0016
960 ACCIDENTAL EXPOSURE TO PRODUCT 169 0.0016
961 BLOOD GLUCOSE INCREASED 305 0.0016
962 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 54 0.0016
963 COMPLETED SUICIDE 133 0.0016
964 INTERSTITIAL LUNG DISEASE 77 0.0016
965 ABNORMAL BEHAVIOUR 63 0.0016
966 INJECTION SITE RASH 47 0.0015
967 THERAPY CESSATION 77 0.0015
968 SUICIDE ATTEMPT 90 0.0015
969 MULTIPLE SCLEROSIS RELAPSE 99 0.0014
970 DRUG-INDUCED LIVER INJURY 45 0.0014
971 EXTRA DOSE ADMINISTERED 58 0.0014
972 INJECTION SITE HAEMORRHAGE 112 0.0014
973 DEVICE BREAKAGE 56 0.0014
974 DRUG EXPOSURE DURING PREGNANCY 46 0.0014
975 DRUG WITHDRAWAL SYNDROME 118 0.0013
976 LUNG NEOPLASM MALIGNANT 55 0.0013
977 ANGER 45 0.0013
978 COLITIS ULCERATIVE 58 0.0013
979 PSORIASIS 168 0.0013
980 DEVICE MALFUNCTION 88 0.0013
981 DISEASE RECURRENCE 59 0.0012
982 SKIN BURNING SENSATION 88 0.0012
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 83 0.0012
984 DERMATITIS ATOPIC 59 0.0011
985 DRUG DOSE OMISSION 181 0.0011
986 DRUG DEPENDENCE 173 0.0011
987 ACNE 80 0.0011
988 DEVICE DIFFICULT TO USE 67 0.0010
989 BREAST CANCER 94 0.0010
990 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 47 0.0010
991 UNDERDOSE 71 0.0010
992 PRODUCT STORAGE ERROR 83 0.0009